In summary, ADAR1 is recurrently associated with tumor-promoting functions across multiple cancer types—via editing of oncogenes (AZIN1, GM2A), suppression of innate immune signaling (PKR/MDA5), and stabilization of key proteins (KYNU). This evidence concerns the gene KYNU and neoplasm.